Search - tctmd.com

Displaying 1 - 20 of 118

Sort: Relevancy | Date

News Conference News ACC 2026

Sirolimus DCB in Peripheral Disease Makes Strides in Hard Outcomes: SirPAD

L.A. McKeown

April 02, 2026

News Conference News ACC 2026

HI-PEITHO: Catheter-Directed Therapy Bests Anticoagulation in Intermediate-Risk PE

L.A. McKeown

March 28, 2026

News Daily News

Apixaban Bests Rivaroxaban for Bleeding in VTE: COBRRA

Yael L. Maxwell

March 16, 2026

News Daily News

AHA/ACC Guideline Tackles Evidence-Based Acute PE Care

L.A. McKeown

February 19, 2026

News Daily News

Patient Age Adds Key Context to D-Dimer in DVT Diagnosis: ADJUST-DVT

Caitlin E. Cox

January 08, 2026

News Daily News

Thrombolysis May Be OK for DOAC-Treated Patients With Ischemic Stroke

Todd Neale

January 07, 2026

News Daily News

Asundexian Reduces Recurrent Stroke Without Bleeding Risk: OCEANIC-STROKE

Michael O'Riordan

November 24, 2025

News Conference News ESC 2025

HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients

Caitlin E. Cox

September 01, 2025

News Daily News

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

L.A. McKeown

July 15, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2025

Caitlin E. Cox

April 01, 2025

News Daily News ACC 2025

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

L.A. McKeown

March 29, 2025

Presentation ACC 2025

Extended Anticoagulant Treatment With A Reduced Versus Full Dose Apixaban In Patients With Cancer-associated Venous Thromboembolism: The API-CAT Study

Presenter: Isabelle Mahé

March 29, 2025

News Conference News ACC 2025

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

Caitlin E. Cox

March 29, 2025

News Conference News ISC 2025

GFAP Biomarker Assay Can Discern ICH vs Ischemic Stroke

Caitlin E. Cox

February 11, 2025

Presentation TCT 2024

Insights from VOYAGER PAD on Anticoagulants in PVI Patients

Presenter: R. Kevin Rogers

October 29, 2024

News Opinion CV Team Dispatch

September 2024 Dispatch for the CV Team

L.A. McKeown

September 01, 2024

News Daily News

Scientific Statement Reviews Current Antithrombotic Options in PAD

L.A. McKeown

August 26, 2024

News Daily News

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

L.A. McKeown

August 19, 2024

News Opinion CV Team Dispatch

August 2024 Dispatch for the CV Team

L.A. McKeown

August 01, 2024

News Opinion CV Team Dispatch

June 2024 Dispatch for the CV Team

L.A. McKeown

June 01, 2024

Advertisement

Sirolimus DCB in Peripheral Disease Makes Strides in Hard Outcomes: SirPAD

HI-PEITHO: Catheter-Directed Therapy Bests Anticoagulation in Intermediate-Risk PE

Apixaban Bests Rivaroxaban for Bleeding in VTE: COBRRA

AHA/ACC Guideline Tackles Evidence-Based Acute PE Care

Patient Age Adds Key Context to D-Dimer in DVT Diagnosis: ADJUST-DVT

Thrombolysis May Be OK for DOAC-Treated Patients With Ischemic Stroke

Asundexian Reduces Recurrent Stroke Without Bleeding Risk: OCEANIC-STROKE

HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

TCTMD’s Top 10 Most Popular Stories for March 2025

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

Extended Anticoagulant Treatment With A Reduced Versus Full Dose Apixaban In Patients With Cancer-associated Venous Thromboembolism: The API-CAT Study

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

GFAP Biomarker Assay Can Discern ICH vs Ischemic Stroke

Insights from VOYAGER PAD on Anticoagulants in PVI Patients

September 2024 Dispatch for the CV Team

Scientific Statement Reviews Current Antithrombotic Options in PAD

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

August 2024 Dispatch for the CV Team

June 2024 Dispatch for the CV Team

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content